At-home Breast Oncology Care Delivered With E-health Solutions The ABODE Study

What this Trial Is About

Researchers are evaluating a new eHealth solution designed for women newly diagnosed with breast cancer to improve virtual care during diagnosis and treatment. The study compares the use of a Breast Cancer Treatment Application (BCTA) with standard care in a randomized controlled trial, aiming to assess patient activation and various patient-reported outcomes over a year. This app helps patients with virtual consultations, provides educational materials, and collects important health information remotely. The trial involves 200 female patients divided into two groups: one receiving standard care and the other receiving standard care plus access to the BCTA for 13 months. Both groups will receive Fitbit devices to monitor physical activity and health data. The study collects data at multiple points including baseline, 6 months, and 12 months post-diagnosis, using surveys and clinical records to measure outcomes such as anxiety, quality of life, and treatment experiences. Participants will complete several questionnaires online and wear Fitbits to track activity levels, sleep, and heart rate throughout the study. Researchers will also review healthcare usage like clinic visits and hospital admissions. The primary measure is the change in patient activation after one year, with secondary measures including other patient-reported outcomes and health service use. The total participation time is approximately 13 to 15 months from enrollment.

At-home Breast Oncology Care Delivered With E-health Solutions